Cautious news tone
News Sentiment
EMBC sentiment intelligence
Embecta Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Cautious news tone is being confirmed by negative weekly price action.
74/100 classification confidence.
directly relevant articles
high-authority source matches
-3.3% over one week, +4.5% over four weeks, trend inactive, and below fair value.
EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff Deadline in Embecta Corp. Securities Class Action - Contact SueWallSt
Market Reaction
Caution confirmed by price
Cautious news tone is being confirmed by negative weekly price action.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Investor Notice: Robbins LLP Informs Investors of the Embecta Corp. Class Action Lawsuit
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 17 Jun 2026 07:00
- Source
- Business Wire
embecta appoints Nimish Muzumdar as SVP and President, North America
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 10:30
- Source
- GlobeNewswire
embecta to Participate in Investor Events
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 21:00
- Source
- GlobeNewswire
What Triggered Embecta's Recent Stock Plunge and Analyst Downgrades
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 24 May 2026 17:45
- Source
- Kavout | AI
Embecta (EMBC) Hit With A Sharp Target Cut As Medtech Sentiment Weakens
- Tone
- Negative 42/100
- Event
- Analyst action
- Published
- 24 May 2026 11:48
- Source
- Insider Monkey
BofA Securities Adjusts Price Target on Embecta to $3 From $11
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 May 2026 12:16
- Source
- MT Newswires
Embecta acquires Owen Mumford for $172.6m
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 11:13
- Source
- Medical Device Network
Embecta closes Owen Mumford acquisition for up to $201M
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 May 2026 11:10
- Source
- MedTech Dive
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 May 2026 07:00
- Source
- Market source
Embecta Closes Acquisition of Owen Mumford
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 May 2026 13:30
- Source
- MT Newswires
S&P Global Ratings Cuts Credit Rating on Embecta (EMBC) After Revenue Decline
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Market source
Embecta (EMBC) Is Down 60.7% After Dividend Cut And Buyback Shift - What's Changed
- Tone
- Negative 34/100
- Event
- Capital return
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Embecta Corp. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Market source
Deeply Undervalued Global Medical Device Company – Embecta Corp. (EMBC)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- The Acquirer's Multiple
Embecta: A Sharp Decline On Q2 Earnings, But There's Still No Opportunity (NASDAQ:EMBC)
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Seeking Alpha
Embecta (EMBC) Margin Expansion To 12.9% Tests Bearish Earnings Sustainability Narrative
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- simplywall.st
Embecta (EMBC): Do Buybacks Amid Losses Reveal Capital Discipline or Strategic Uncertainty?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Market source
Guidance cut, buyback and dividend reduction at Embecta (Nasdaq: EMBC)
- Tone
- Negative 34/100
- Event
- Capital return
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
BTIG downgrades Embecta stock rating on U.S. market share loss
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 05 May 2026 07:00
- Source
- Investing.com
Earnings call transcript: Embecta Q2 2026 sees sharp earnings miss, stock plunges
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Investing.com
Embecta Insider Ups Holding By 13% During Year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2026 07:00
- Source
- simplywall.st
Is Embecta (EMBC) One of the 10 Healthcare Stocks with Highest Dividends?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
Should You Investigate Embecta Corp. (NASDAQ:EMBC) At US$8.88?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Market source
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 09 Feb 2026 08:00
- Source
- simplywall.st
Embecta Corp. SEC 10-Q Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- TradingView
Embecta stock ticks up on Street-beating Q1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- Drug Delivery Business
Is Now The Time To Look At Buying Embecta Corp. (NASDAQ:EMBC)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Nov 2025 07:00
- Source
- simplywall.st